HBOT for Migraines: Exploring a Promising Option at Chicago Neuro

A migraine is not just a bad headache—it’s a full-body experience that can derail a day, a week, or even a life. Throbbing pain, visual disturbances, nausea, and light sensitivity make it hard to function, much less thrive. For many, conventional strategies like medication and lifestyle changes only provide partial relief. At Chicago Neuro, hyperbaric oxygen therapy (HBOT) is being explored as a fresh approach to help reduce the intensity and frequency of migraines through a novel lens: oxygenation and neurovascular support.
When the Head Becomes the Battlefield
Migraines affect more than 1 billion people globally, with women being disproportionately impacted. These aren’t ordinary headaches; they often involve neurological symptoms like aura, cognitive fog, and sensory hypersensitivity. In severe cases, migraines interfere with relationships, careers, and daily responsibilities.
Most research points to a combination of genetic, hormonal, environmental, and neurological factors. Blood vessel constriction, abnormal brain activity, and inflammatory processes all play a role. While medication can interrupt some of these patterns, it often falls short when migraines are chronic or resistant.
Why Oxygen Matters in Migraine Physiology
Oxygen might seem like an unusual angle in migraine care, but it’s central to how the brain functions. The brain consumes about 20% of the body’s oxygen supply. Even a minor dip in oxygen levels can lead to fatigue, fogginess, or, in sensitive individuals, the onset of a migraine.
Research suggests that the early phases of a migraine—particularly the aura stage—may involve a wave of disrupted blood flow, known as cortical spreading depression. This disturbance can create temporary low-oxygen zones in the brain. HBOT works by saturating the bloodstream with oxygen under pressure, helping oxygen reach deeper tissues, including areas affected by restricted blood flow.
How HBOT Works
Hyperbaric oxygen therapy involves placing the individual in a sealed chamber where they breathe 100% oxygen at higher-than-normal atmospheric pressure. This increases the oxygen-carrying capacity of the blood plasma, not just the red blood cells.
The results? A cascade of benefits, including:
-
Enhanced cellular metabolism
-
Reduced inflammation
-
Improved blood vessel function
-
Stabilization of brain chemistry
At Chicago Neuro, this technology is applied with precision. The goal is not just symptom management, but creating an environment where the brain is less likely to spiral into a migraine episode.
Neurological Foundations of HBOT for Migraines
Balancing Neurotransmitters Migraines are often associated with imbalances in serotonin, dopamine, and other brain chemicals. Studies show that oxygen therapy can help stabilize neurotransmitter activity, potentially lowering the risk of chemical triggers that set migraines off.
Reducing Neuroinflammation Inflammation in the brain can sensitize nerve endings and lower pain thresholds. HBOT reduces pro-inflammatory cytokines and increases antioxidant defenses. This may help decrease hypersensitivity and discomfort over time.
Improving Cerebral Blood Flow Migraine sufferers often experience vascular irregularities—either constriction or dilation of blood vessels. HBOT improves vascular tone and may help smooth out the erratic blood flow patterns seen in migraine phases.
Restoring Mitochondrial Function Cellular energy production is crucial to brain health. Mitochondria—the powerhouses of cells—often underperform in individuals prone to migraines. By flooding cells with oxygen, HBOT supports mitochondrial function and energy balance.
What the Research Says
While HBOT for migraines is still an emerging field, early findings are promising:
-
A 2008 review in the Cochrane Database found that HBOT showed potential for stopping migraine attacks when applied early.
-
A 2018 pilot study showed that HBOT reduced headache frequency and improved quality of life for participants over a 4-week period.
-
A recent 2021 study published in Medical Gas Research found improvements in pain scores and decreased reliance on medications among patients who received HBOT.
Although more randomized trials are needed, anecdotal evidence from patients at Chicago Neuro mirrors these findings—people report fewer episodes, improved mood, and better cognitive clarity.
Beyond the Oxygen: Customizing Care at Chicago Neuro
Migraines are personal. Triggers vary—from stress and dehydration to hormonal shifts and environmental sensitivities. At Chicago Neuro, HBOT is integrated into broader, individualized care plans.
Patients undergo comprehensive evaluations, including brain scans, neurological assessments, and lifestyle mapping. From there, HBOT is used in combination with other non-invasive interventions such as:
-
Neurofeedback
-
Nutritional therapy
-
Sleep optimization
-
Craniosacral therapy
This multidisciplinary model ensures that oxygen therapy supports—not replaces—other migraine-reducing strategies.
Real-World Transformation
Consider a 35-year-old professional who’s been missing work due to four or five migraines a month. Medications offer limited reprieve and leave her feeling groggy. After 6 weeks of HBOT at Chicago Neuro, her episodes drop to once every 10 days, and their severity decreases significantly.
It’s not just the headaches that improve. With fewer interruptions, she reports feeling more emotionally balanced, mentally sharp, and physically energized. HBOT doesn’t erase migraines overnight—but it shifts the terrain in favor of brain stability.
Addressing Concerns and Myths
Is HBOT safe? Yes, when administered by trained clinicians. Mild side effects may include ear pressure or fatigue post-session, but these are generally temporary.
Is it covered by insurance? Currently, HBOT is often considered off-label for migraines, so coverage may vary. However, Chicago Neuro offers flexible plans and payment options.
Is it just a placebo? Controlled studies and biological markers—like lowered inflammatory cytokines and improved oxygen saturation—support its physiological impact beyond the placebo effect.
Who Might Benefit Most?
HBOT may be a useful addition for:
-
Chronic migraine sufferers
-
People with medication-resistant migraines
-
Those with a history of head trauma
-
Individuals sensitive to pharmaceutical side effects
It may also offer hope for people who have exhausted conventional options and are seeking a fresh, science-backed approach.
The Road Ahead
As understanding of the brain evolves, so does the potential of oxygen therapy. HBOT represents a bridge between conventional neurology and integrative innovation. It doesn’t compete with other therapies—it amplifies them.
At Chicago Neuro, the focus is not just on reducing headache days, but on enhancing brain health, emotional resilience, and overall vitality. With the right guidance, oxygen may become one of the most valuable tools in a migraine sufferer’s toolkit.
For more information about HBOT, call (312) 767-3500 or find an Oxygen therapy clinic near you.
Resources:
- Peterson T, AbouAssaly J, Burgin S, Sherwin R, Strale F Jr. Long-Term Effects of Neurofeedback and Hyperbaric Oxygen Therapy on Traumatic Brain Injury: A Principal Component Analysis (PCA)-Based Secondary Analysis. Cureus. 2024 Nov 23;16(11):e74305. doi: 10.7759/cureus.74305. PMID: 39717339; PMCID: PMC11666294.
- Liska GM, Lippert T, Russo E, Nieves N, Borlongan CV. A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells. Cond Med. 2018 Jun;1(4):151-166. PMID: 30079404; PMCID: PMC6075658.
- Hajek M, Jor O, Tlapak J, Chmelar D. Hyperbaric Oxygen Therapy in Children with Brain Injury: A Retrospective Case Series. Int J Med Sci. 2025 Jan 1;22(3):473-481. doi: 10.7150/ijms.102884. PMID: 39898239; PMCID: PMC11783073.
- Yang C, Liu G, Zeng X, Xiang Y, Chen X, Le W. Therapeutic effects of long-term HBOT on Alzheimer’s disease neuropathologies and cognitive impairment in APPswe/PS1dE9 mice. Redox Biol. 2024 Apr;70:103006. doi: 10.1016/j.redox.2023.103006. Epub 2023 Dec 23. PMID: 38241837; PMCID: PMC10831255.